Aridis Pharmaceuticals Q3 EPS $0.00 Up From $(0.47) YoY, Sales $417.00K Up From $399.00K YoY
Portfolio Pulse from Benzinga Newsdesk
Aridis Pharmaceuticals reported Q3 earnings per share (EPS) of $0.00, up from $(0.47) year over year (YoY). The company's sales also increased to $417.00K from $399.00K YoY.
November 03, 2023 | 8:17 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aridis Pharmaceuticals' Q3 earnings per share (EPS) improved YoY, and sales also increased. This could indicate a positive financial performance.
Aridis Pharmaceuticals reported an improvement in its Q3 earnings per share (EPS) and an increase in sales YoY. This indicates a positive financial performance, which could potentially lead to a rise in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100